Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD

Published:2023-01 Issue:1 Volume:163 Page:100-114
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Chen Hong,Deng Zheng-Xu,Sun Jian,Huang Qiang,Huang Lan,He Yong-Hong,Ma Chunlan,Wang Ke

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference79 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012

2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010;Vos;Lancet,2012

3. Pharmacotherapy and lung function decline in patients with chronic obstructive pulmonary disease. A systematic review;Celli;Am J Respir Crit Care Med,2021

4. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease;Calverley;N Engl J Med,2007

5. Once-daily single-inhaler triple versus dual therapy in patients with COPD;Lipson;N Engl J Med,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effect of ginkgetin on smoke-induced airway inflammation by down-regulating the c/EBPβ signaling pathway and CCL2 expression;Journal of Ethnopharmacology;2024-09

2. Survival benefit of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a nationwide cohort study;Scientific Reports;2024-06-26

3. Comparing the Efficacy of Inhaled Corticosteroid (ICS) Treatment in COPD Patients Based on Blood Eosinophilia: A Clinical Trial Study;Zahedan Journal of Research in Medical Sciences;2024-05-07

4. Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History;Biomolecules;2024-02-06

5. Comparative effectiveness and safety of triple therapy and non-triple therapy interventions for COPD: an overview of systematic reviews;Therapeutic Advances in Respiratory Disease;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3